Nitrous Oxide Lawsuit

106 results
Plaintiffs and defendants involved in hair relaxer lawsuits have filed competing plans which differ in how they would select 16 cases to serve as bellwether early test cases, and also differ in when they would be ready for trial.
Judge presiding over all federal hair relaxer lawsuits has ordered the parties to submit separate briefing on the bellwether selection process by January 3.
Status report on hair relaxer lawsuits reveals that plaintiffs are still awaiting key information about the ingredients contained in specific hair straighteners sold by cosmetics manufacturers, as part of the discovery process leading up to early bellwether trials.
Spouses and surviving family members continue to bring hair relaxer wrongful death lawsuits against manufacturers of products that contain chemicals now known to increase the risk of cancer.
Lawyers will meet today with the federal judge presiding over all hair relaxer lawsuits, as women diagnosed with uterine, endometrial and ovarian cancer continue to file claims throughout the U.S. court system.
Lawyers will report to a U.S. Magistrate Judge about the status of hair relaxer lawsuits, to keep the litigation on track as the Court prepares claims brought by women diagnosed with uterine cancer, endometrial cancer and ovarian cancer for trial.
With hair relaxer lawsuits being pursued throughout the federal court system by women diagnosed with uterine cancer, endometrial cancer and ovarian cancer, the U.S. District Judge presiding over the litigation has directed parties to finish general discovery by September 2025.
U.S. District Judge presiding over all federal hair relaxer lawsuits will meet with lawyers involved in the litigation on Thursday, to discuss the status of the claims and when to move forward with bellwether cases.
Court rejected a motion to dismiss the hair relaxer class actions lawsuits, which seek economic damages for consumers exposed to toxic chemicals in the products, which are now known to increase the risk of uterine cancer, ovarian cancer and other injuries.
Three U.S. House Representatives are asking the FDA to explain why it has repeatedly delayed a proposed ban on formaldehyde in hair relaxer products, after determining they carry an increased cancer risk.
Notifications